Revenue | ₹1.32Cr |
Net Profits | ₹0.02Cr |
Net Profit Margins | 1.52% |
Venmax Drugs & Pharmaceuticals Ltd’s revenue jumped 676.47% since last year same period to ₹1.32Cr in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 9.09% jump in its revenue since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 106.67% since last year same period to ₹0.02Cr in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -50% fall in its net profits since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit margin jumped 100.86% since last year same period to 1.52% in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -54.17% fall in its net profit margins since last 3-months.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹1.32Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was ₹0.02Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2025 was 1.52%.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.17Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.30Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q2 results 2024 was -176.47%.